The AI-driven platform identifies cell cycle deregulation and tumor immune microenvironment dynamics from biopsy images.
Together, AMD, Oracle, and 4D Path are redefining the role of CPUs in powering next-generation AI for clinical trials and precision oncology.
TipRanks on MSN
4DMedical expands US presence with key partnerships
The latest announcement is out from 4DMedical Ltd ( ($AU:4DX) ). 4DMedical Limited has announced that the University of Miami has adopted its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback